Trial Profile
A retrospective trial of trabectedin in women with advanced ovarian carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jan 2016
Price :
$35
*
At a glance
- Drugs Trabectedin (Primary) ; Doxorubicin liposomal
- Indications Fallopian tube cancer; Ovarian cancer
- Focus Therapeutic Use
- 21 Jan 2016 New trial record